Sumann G, Krismer A C, Wenzel V, Adelsmayr E, Schwarz B, Lindner K H, Mair P
Departments of Anesthesiology and Critical Care Medicine, Leopold-Franzens-University, Innsbruck, Austria.
Acta Anaesthesiol Scand. 2003 Mar;47(3):363-5. doi: 10.1034/j.1399-6576.2003.00017.x.
Recent animal data have challenged the common clinical practice to avoid vasopressor drugs during hypothermic cardiopulmonary resuscitation (CPR) when core temperature is below 30 degrees C. In this report, we describe the case of a 19-year-old-female patient with prolonged, hypothermic, out-of-hospital cardiopulmonary arrest after near drowning (core temperature, 27 degrees C) in whom cardiocirculatory arrest persisted despite 2 mg of intravenous epinephrine; but, immediate return of spontaneous circulation occurred after a single dose (40 IU) of intravenous vasopressin. The patient was subsequently admitted to a hospital with stable haemodynamics, and was successfully rewarmed with convective rewarming, but died of multiorgan failure 15 h later. To the best of our knowledge, this is the first report about the use of vasopressin during hypothermic CPR in humans. This case report adds to the growing evidence that vasopressors may be useful to restore spontaneous circulation in hypothermic cardiac arrest patients prior to rewarming, thus avoiding prolonged mechanical CPR efforts, or usage of extracorporeal circulation. It may also support previous experience that the combination of both epinephrine and vasopressin may be necessary to achieve the vasopressor response needed for restoration of spontaneous circulation, especially after asphyxial cardiac arrest or during prolonged CPR efforts.
近期的动物实验数据对低温心肺复苏(CPR)期间,当核心体温低于30摄氏度时避免使用血管加压药物这一常见临床做法提出了挑战。在本报告中,我们描述了一名19岁女性患者的病例,该患者在近乎溺水后发生长时间、低温的院外心脏骤停(核心体温27摄氏度),尽管静脉注射了2毫克肾上腺素,心脏循环骤停仍持续存在;但是,在静脉注射单剂量(40国际单位)血管加压素后,立即恢复了自主循环。该患者随后被收治入院,血流动力学稳定,并通过对流复温成功复温,但15小时后死于多器官功能衰竭。据我们所知,这是关于在人类低温CPR期间使用血管加压素的首例报告。该病例报告进一步证明,血管加压药物可能有助于在复温前恢复低温心脏骤停患者的自主循环,从而避免长时间的机械CPR操作或体外循环的使用。这也可能支持先前的经验,即肾上腺素和血管加压素联合使用可能是恢复自主循环所需的血管加压反应所必需的,尤其是在窒息性心脏骤停后或长时间CPR操作期间。